Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5396PDF: 1377HTML: 2867Cover letter: 225 -
The diagnostic pitfalls of mucormycosis
1013PDF: 746HTML: 290 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3412PDF: 608HTML: 725 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1528PDF: 949Suppl. Files: 471HTML: 296 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2139PDF: 1089HTML: 15736COVER LETTER: 212 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1072PDF: 390HTML: 243 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4581PDF: 1521HTML: 8537 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3677PDF: 1589HTML: 4498CoverLetter: 204Figure1: 221 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3518PDF: 1238HTML: 505 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2785PDF: 988HTML: 633 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3367PDF: 1587HTML: 477 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1011PDF: 551HTML: 223 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1453PDF: 1018HTML: 2034Cover letter: 219 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2653PDF: 977HTML: 593 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5785PDF: 1566HTML: 1663Untitled: 258 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1347PDF: 1001HTML: 98 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1289PDF: 971HTML: 345 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2535PDF: 1299HTML: 3617Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 437 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3721PDF: 1152HTML: 23375 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1094PDF: 958Suppl. Files: 611HTML: 104 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1831PDF: 583HTML: 16994Figure 4: 192Figure 3: 162Figure 2: 168Figure 1: 204 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
808PDF: 583HTML: 281 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3800PDF: 1305HTML: 3927Untitled: 258Untitled: 290







